These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34593797)

  • 21. SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms.
    He J; Zhou M; Li X; Gu S; Cao Y; Xing T; Chen W; Chu C; Gu F; Zhou J; Jin Y; Ma J; Ma D; Zou Q
    Oncogene; 2020 Mar; 39(13):2658-2675. PubMed ID: 32005974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits.
    Rhie SK; Guo Y; Tak YG; Yao L; Shen H; Coetzee GA; Laird PW; Farnham PJ
    Epigenetics Chromatin; 2016; 9():50. PubMed ID: 27833659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-23a inhibits the growth of papillary thyroid carcinoma via regulating cyclin G1.
    Yin JJ; Cheng XY
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3431-3439. PubMed ID: 31081097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-Omics Analysis for Transcriptional Regulation of Immune-Related Targets Using Epigenetic Data: A New Research Direction.
    Huang C; Zhang N; Xiong H; Wang N; Chen Z; Ni Z; Liu X; Lin B; Ge B; Du B; Huang Q
    Front Immunol; 2021; 12():741634. PubMed ID: 35046932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-548c-3p suppressed the progression of papillary thyroid carcinoma via inhibition of the HIF1α-mediated VEGF signaling pathway.
    Du Y; Zhu J; Chu BF; Yang YP; Zhang SL
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6570-6578. PubMed ID: 31378898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromatin-Accessible miRNA Regulons Driving Thyroid Tumorigenesis and Progression.
    Toraih EA; Ruiz E; Ning B; Tortelote GG; Hilliard S; Moroz K; Hu T; Fawzy MS; Kandil E
    J Am Coll Surg; 2023 Apr; 236(4):732-750. PubMed ID: 36728308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early adaptive chromatin remodeling events precede pathologic phenotypes and are reinforced in the failing heart.
    Chapski DJ; Cabaj M; Morselli M; Mason RJ; Soehalim E; Ren S; Pellegrini M; Wang Y; Vondriska TM; Rosa-Garrido M
    J Mol Cell Cardiol; 2021 Nov; 160():73-86. PubMed ID: 34273410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.
    Beltrami CM; Dos Reis MB; Barros-Filho MC; Marchi FA; Kuasne H; Pinto CAL; Ambatipudi S; Herceg Z; Kowalski LP; Rogatto SR
    Clin Epigenetics; 2017; 9():45. PubMed ID: 28469731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell lymphoma 2 family genes show a molecular pattern of spatiotemporal heterogeneity in gynaecologic and breast cancer.
    Wang J; Li S; Lin S; Fu S; Qiu L; Ding K; Liang K; Du H
    Cell Prolif; 2020 Jun; 53(6):e12826. PubMed ID: 32419250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reception of Sex Steroid Hormones in Thyroid Papillary Cancer Tissue and Relationship with Expression and Content of Transcription Factors Brn-3α and TRIM16.
    Spirina LV; Chizhevskaya SY; Kondakova IV; Choinzonov EL
    Bull Exp Biol Med; 2018 Dec; 166(2):237-240. PubMed ID: 30488195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-96-5p promotes the proliferation, invasion and metastasis of papillary thyroid carcinoma through down-regulating CCDC67.
    Liu ZM; Wu ZY; Li WH; Wang LQ; Wan JN; Zhong Y
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3421-3430. PubMed ID: 31081096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.
    Sancisi V; Manzotti G; Gugnoni M; Rossi T; Gandolfi G; Gobbi G; Torricelli F; Catellani F; Faria do Valle I; Remondini D; Castellani G; Ragazzi M; Piana S; Ciarrocchi A
    Nucleic Acids Res; 2017 Nov; 45(19):11249-11267. PubMed ID: 28981843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance.
    Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY
    Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-146b measurement in FNA to distinguish papillary thyroid cancer from benign thyroid masses.
    Yang F; Zhang H; Leng X; Hao F; Wang L
    Br J Biomed Sci; 2018 Jan; 75(1):43-45. PubMed ID: 28937915
    [No Abstract]   [Full Text] [Related]  

  • 36. Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
    Chen L; Xiong L; Hong S; Li J; Huo Z; Li Y; Chen S; Zhang Q; Zhao R; Gingold JA; Zhu X; Lv W; Li Y; Yu S; Xiao H
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32492708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simple oligonucleotide-based multiplexing of single-cell chromatin accessibility.
    Wang K; Xiao Z; Yan Y; Ye R; Hu M; Bai S; Sei E; Qiao Y; Chen H; Lim B; Lin SH; Navin NE
    Mol Cell; 2021 Oct; 81(20):4319-4332.e10. PubMed ID: 34686316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of key genes of papillary thyroid carcinoma by integrated bioinformatics analysis.
    Xue G; Lin X; Wu JF; Pei D; Wang DM; Zhang J; Zhang WJ
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32766727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma.
    Cao W; Lee H; Wu W; Zaman A; McCorkle S; Yan M; Chen J; Xing Q; Sinnott-Armstrong N; Xu H; Sailani MR; Tang W; Cui Y; Liu J; Guan H; Lv P; Sun X; Sun L; Han P; Lou Y; Chang J; Wang J; Gao Y; Guo J; Schenk G; Shain AH; Biddle FG; Collisson E; Snyder M; Bivona TG
    Nat Commun; 2020 Jul; 11(1):3675. PubMed ID: 32699215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer.
    He H; Li W; Liyanarachchi S; Srinivas M; Wang Y; Akagi K; Wang Y; Wu D; Wang Q; Jin V; Symer DE; Shen R; Phay J; Nagy R; de la Chapelle A
    Proc Natl Acad Sci U S A; 2015 May; 112(19):6128-33. PubMed ID: 25918370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.